Co-Authors
This is a "connection" page, showing publications co-authored by Florian Klein and Lutz Gieselmann.
Connection Strength
2.048
-
Effective high-throughput isolation of fully human antibodies targeting infectious pathogens. Nat Protoc. 2021 07; 16(7):3639-3671.
Score: 0.947
-
Evaluation of a Rapid Antigen Test To Detect SARS-CoV-2 Infection and Identify Potentially Infectious Individuals. J Clin Microbiol. 2021 08 18; 59(9):e0089621.
Score: 0.241
-
Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans. Cell Host Microbe. 2021 06 09; 29(6):917-929.e4.
Score: 0.236
-
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients. Cell. 2020 09 17; 182(6):1663-1673.
Score: 0.226
-
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients. Cell. 2020 08 20; 182(4):843-854.e12.
Score: 0.223
-
Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur. 2021 Jul; 6:100122.
Score: 0.059
-
Evaluation of a New Spike (S)-Protein-Based Commercial Immunoassay for the Detection of Anti-SARS-CoV-2 IgG. Microorganisms. 2021 Mar 31; 9(4).
Score: 0.059
-
Development and characterization of an indirect ELISA to detect SARS-CoV-2 spike protein-specific antibodies. J Immunol Methods. 2021 03; 490:112958.
Score: 0.058